Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absolute Bioavailability of LY4064809 in Healthy Adult Participants
NCT07519525Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tersolisib, sponsored by Eli Lilly and Company. Primary endpoint: Absolute Bioavailability at Day 14. Started Mar 2026; status: completed.
02
Drugs
tersolisib
Beyond the preview
Go deeper on NCT07519525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519525.